Zobrazeno 1 - 10
of 488
pro vyhledávání: '"Reyners AKL"'
Autor:
Bleckman RF; Department of Medical Oncology and Pathology, University Medical Center Groningen, University of Groningen, The Netherlands., Haag CMSC; Department of Medical Oncology and Pathology, University Medical Center Groningen, University of Groningen, The Netherlands., Rifaela N; Department of Medical Oncology and Pathology, University Medical Center Groningen, University of Groningen, The Netherlands., Beukema G; Department of Medical Oncology and Pathology, University Medical Center Groningen, University of Groningen, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, The Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Cleven A; Department of Medical Oncology and Pathology, University Medical Center Groningen, University of Groningen, The Netherlands.; Department of Medical Oncology, Leiden University Medical Center, The Netherlands., Ter Elst A; Department of Medical Oncology and Pathology, University Medical Center Groningen, University of Groningen, The Netherlands., Schuuring E; Department of Medical Oncology and Pathology, University Medical Center Groningen, University of Groningen, The Netherlands., Reyners AKL; Department of Medical Oncology and Pathology, University Medical Center Groningen, University of Groningen, The Netherlands.
Publikováno v:
Molecular oncology [Mol Oncol] 2024 Nov; Vol. 18 (11), pp. 2658-2667. Date of Electronic Publication: 2024 May 24.
Autor:
Eerkens AL; Department of Obstetrics and Gynaecology, University Medical Centre Groningen, Groningen, The Netherlands., Brummel K; Department of Obstetrics and Gynaecology, University Medical Centre Groningen, Groningen, The Netherlands., Vledder A; Department of Obstetrics and Gynaecology, University Medical Centre Groningen, Groningen, The Netherlands., Paijens ST; Department of Radiotherapy, Erasmus University Medical Centre, Rotterdam, The Netherlands., Requesens M; Department of Obstetrics and Gynaecology, University Medical Centre Groningen, Groningen, The Netherlands., Loiero D; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., van Rooij N; Department of Obstetrics and Gynaecology, University Medical Centre Groningen, Groningen, The Netherlands., Plat A; Department of Obstetrics and Gynaecology, University Medical Centre Groningen, Groningen, The Netherlands., Haan FJ; Department of Obstetrics and Gynaecology, University Medical Centre Groningen, Groningen, The Netherlands., Klok P; Department of Obstetrics and Gynaecology, University Medical Centre Groningen, Groningen, The Netherlands., Yigit R; Department of Obstetrics and Gynaecology, University Medical Centre Groningen, Groningen, The Netherlands., Roelofsen T; Department of Obstetrics and Gynaecology, University Medical Centre Groningen, Groningen, The Netherlands., de Lange NM; Department of Obstetrics and Gynaecology, Isala, Zwolle, The Netherlands., Klomp R; Department of Obstetrics and Gynaecology, Treant, Emmen, The Netherlands., Church D; Welcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, United Kingdom., Ter Elst A; Department of Pathology and Medical Biology, University Medical Centre Groningen, Groningen, The Netherlands., Wardenaar R; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands., Spierings D; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands., Foijer F; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands., Koelzer VH; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Bosse T; Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands., Bart J; Department of Pathology and Medical Biology, University Medical Centre Groningen, Groningen, The Netherlands., Jalving M; Department of Medical Oncology, University Medical Centre Groningen, Groningen, The Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Centre Groningen, Groningen, The Netherlands., de Bruyn M; Department of Obstetrics and Gynaecology, University Medical Centre Groningen, Groningen, The Netherlands. m.de.bruyn@umcg.nl., Nijman HW; Department of Obstetrics and Gynaecology, University Medical Centre Groningen, Groningen, The Netherlands. h.w.nijman@umcg.nl.
Publikováno v:
Nature communications [Nat Commun] 2024 Sep 03; Vol. 15 (1), pp. 7695. Date of Electronic Publication: 2024 Sep 03.
Autor:
van der Kleij MBA; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands. m.vd.kleij@nki.nl.; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. m.vd.kleij@nki.nl., Guchelaar NAD; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Meertens M; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Westerdijk K; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Centre, Nijmegen, The Netherlands., Giraud EL; Department of Pharmacy and Clinical Pharmacology, Research Institute for Medical Innovation, Radboud University Medical Centre, Nijmegen, The Netherlands., Bleckman RF; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Groenland SL; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands., van Eerden RAG; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Imholz ALT; Department of Medical Oncology, Deventer Hospital, Deventer, The Netherlands., Vulink AJE; Department of Medical Oncology, Reinier de Graaf Hospital, Delft, The Netherlands., Otten HM; Department of Medical Oncology, Meander Medical Centre, Amersfoort, The Netherlands., Fiebrich-Westra HB; Department of Medical Oncology, Isala Hospital, Zwolle, The Netherlands., Lubberman FJE; Department of Pharmacy, Gelderse Vallei Hospital, Ede, The Netherlands., Desar IME; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Centre, Nijmegen, The Netherlands., Moes DAR; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Centre, Leiden, The Netherlands., Touw DJ; Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Pharmacy, Erasmus University Medical Centre, Rotterdam, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., van Erp NP; Department of Pharmacy and Clinical Pharmacology, Research Institute for Medical Innovation, Radboud University Medical Centre, Nijmegen, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, Utrecht University Medical Centre, Utrecht, The Netherlands.; Department of Pharmacology, Princess Máxima Centre for Paediatric Oncology, Utrecht, The Netherlands., Steeghs N; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Medical Oncology, Utrecht University Medical Centre, Utrecht University, Utrecht, The Netherlands.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Sep; Vol. 131 (5), pp. 843-851. Date of Electronic Publication: 2024 Jul 06.
Autor:
Xander NSH; Department of Health Technology Assessment, Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA Rotterdam, the Netherlands; Erasmus Centre for Health Economics Rotterdam, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA Rotterdam, the Netherlands. Electronic address: xander@eshpm.eur.nl., Leeneman B; Department of Health Technology Assessment, Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA Rotterdam, the Netherlands; Erasmus Centre for Health Economics Rotterdam, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA Rotterdam, the Netherlands., Dingemans AC; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Erasmus Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands., Fiets WE; Department of Medical Oncology, Medical Center Leeuwarden, Henri Dunantweg 2, 8934 AD Leeuwarden, the Netherlands., de Jong WK; Department of Pulmonology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands., Uyl NEM; Department of Health Technology Assessment, Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA Rotterdam, the Netherlands., Wymenga ANM; Department of Medical Oncology, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ Enschede, the Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, the Netherlands., Uyl-de Groot CA; Department of Health Technology Assessment, Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA Rotterdam, the Netherlands; Erasmus Centre for Health Economics Rotterdam, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA Rotterdam, the Netherlands.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Sep; Vol. 209, pp. 114262. Date of Electronic Publication: 2024 Aug 03.
Autor:
Hulskotte LMG; Department of Clinical Pharmacy, Deventer Teaching Hospital, Nico, Bolkesteinlaan 75, 7416 SE, Deventer, the Netherlands. l.hulskotte@dz.nl.; Unit of PharmacoTherapy, -Epidemiology &-Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, the Netherlands. l.hulskotte@dz.nl., Töpfer W; Unit of PharmacoTherapy, -Epidemiology &-Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, the Netherlands., Reyners AKL; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Taxis K; Unit of PharmacoTherapy, -Epidemiology &-Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, the Netherlands., Jansman FGA; Department of Clinical Pharmacy, Deventer Teaching Hospital, Nico, Bolkesteinlaan 75, 7416 SE, Deventer, the Netherlands.; Unit of PharmacoTherapy, -Epidemiology &-Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, the Netherlands.
Publikováno v:
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 Mar; Vol. 80 (3), pp. 455-464. Date of Electronic Publication: 2024 Jan 13.
Autor:
van Poelgeest MIE; Department of Gynecology and Obstetrics, Leiden University Medical Center, Leiden, The Netherlands shvdburg@lumc.nl M.I.E.van_Poelgeest@lumc.nl., Kortekaas KE; Department of Gynecology and Obstetrics, Leiden University Medical Center, Leiden, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., van Doorn HC; Department of Gynecologic Oncology, Erasmus MC, Rotterdam, Zuid-Holland, The Netherlands., Oonk M; Department of Obstetrics and Gynecology, University Medical Centre Groningen, Groningen, Groningen, The Netherlands., Nijman HW; Department of Obstetrics and Gynecology, University Medical Centre Groningen, Groningen, Groningen, The Netherlands., Boere I; Department of Medical Oncology, Erasmus MC, Rotterdam, Zuid-Holland, The Netherlands., Eerkens AL; Department of Obstetrics and Gynecology, University Medical Centre Groningen, Groningen, Groningen, The Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Centre Groningen, Groningen, Groningen, The Netherlands., Ewing-Graham PC; Department of Pathology, Erasmus MC, Rotterdam, Zuid-Holland, The Netherlands., Bart J; Department of Pathology, University Medical Centre Groningen, Groningen, Groningen, The Netherlands., Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Welters MJP; Oncode Institute, Utrecht, The Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., van der Burg SH; Oncode Institute, Utrecht, The Netherlands shvdburg@lumc.nl M.I.E.van_Poelgeest@lumc.nl.; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Jul 02. Date of Electronic Publication: 2024 Jul 02.
Autor:
Verkouteren BJA; Department of Dermatology, Maastricht University Medical Center, Maastricht, The Netherlands.; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Aarts MJB; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands., Mosterd K; Department of Dermatology, Maastricht University Medical Center, Maastricht, The Netherlands.; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
Publikováno v:
Case reports in dermatology [Case Rep Dermatol] 2024 Jun 27; Vol. 16 (1), pp. 173-180. Date of Electronic Publication: 2024 Jun 27 (Print Publication: 2024).
Autor:
Schouten B; Department of Public and Occupational Health, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, P/O Box 7057, De Boelelaan 1117, Amsterdam, 1007 MB, The Netherlands. b.schouten1@amsterdamumc.nl., van Schoten SM; Department of Public and Occupational Health, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, P/O Box 7057, De Boelelaan 1117, Amsterdam, 1007 MB, The Netherlands., Bijnsdorp FM; Netherlands Institute for Health Services Research (Nivel), Utrecht, The Netherlands., Merten H; Department of Public and Occupational Health, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, P/O Box 7057, De Boelelaan 1117, Amsterdam, 1007 MB, The Netherlands., Nanayakkara PWB; Section General Internal Medicine, Department of Internal Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, De Boelelaan 1117, Amsterdam, The Netherlands., Reyners AKL; Department of Medical Oncology, Center of Expertise in Palliative Care, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Francke AL; Department of Public and Occupational Health, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, P/O Box 7057, De Boelelaan 1117, Amsterdam, 1007 MB, The Netherlands.; Netherlands Institute for Health Services Research (Nivel), Utrecht, The Netherlands.; Expertise Center Palliative Care, Amsterdam UMC, Amsterdam, The Netherlands., Wagner C; Department of Public and Occupational Health, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, P/O Box 7057, De Boelelaan 1117, Amsterdam, 1007 MB, The Netherlands.; Netherlands Institute for Health Services Research (Nivel), Utrecht, The Netherlands.
Publikováno v:
BMC palliative care [BMC Palliat Care] 2024 Jun 10; Vol. 23 (1), pp. 145. Date of Electronic Publication: 2024 Jun 10.
Autor:
Giraud EL; Department of Pharmacy, Radboud University Medical Center, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: https://twitter.com/ElineGirau45556., Westerdijk K; Department of Medical Oncology, Radboud University Medical Center, Radboud University Medical Center, Nijmegen, The Netherlands., van der Kleij MBA; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Guchelaar NAD; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Meertens M; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Bleckman RF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Rieborn A; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Mohammadi M; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Roets E; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; Department of Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Moes DJAR; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Touw DJ; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Keizer-Heldens P; Department of Medical Oncology, Rijnstate Hospital, Arnhem, The Netherlands., Oosten AW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van der Graaf WTA; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Erp NP; Department of Pharmacy, Radboud University Medical Center, Radboud University Medical Center, Nijmegen, The Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Center, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Ingrid.desar@radboudumc.nl.
Publikováno v:
ESMO open [ESMO Open] 2024 Jun; Vol. 9 (6), pp. 103477. Date of Electronic Publication: 2024 Jun 03.
Autor:
Heipon CS; Department of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands. c.heipon@iknl.nl., Brom L; Department of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., van der Linden YM; Department of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.; Department of Radiotherapy, Leiden University Medical Centre, Leiden, the Netherlands., Tange D; Dutch Federation of Cancer Patients Organisations, Utrecht, the Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Raijmakers NJH; Department of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 May 03; Vol. 32 (5), pp. 324. Date of Electronic Publication: 2024 May 03.